In a landmark study published in the prestigious New England Journal of Medicine, ChloraPrep skin antiseptic clearly outperformed iodine-based products against surgical-site infections. ChloraPrep reduced total surgical site infections by 41% versus povidone-iodine [9.5% vs 16.1%, respectively]. The study's results echo those of many others in which ChloraPrep® skin antiseptic outperforms iodine-based products.
For more information, call (800) 523-0502, visit www.chloraprep.com or click on "Learn More" below.
Your product information request has been received and we will forward information to the contact information you provided shortly.